BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17446350)

  • 1. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice.
    Heib V; Becker M; Warger T; Rechtsteiner G; Tertilt C; Klein M; Bopp T; Taube C; Schild H; Schmitt E; Stassen M
    Blood; 2007 Aug; 110(3):946-53. PubMed ID: 17446350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells.
    Fishelevich R; Zhao Y; Tuchinda P; Liu H; Nakazono A; Tammaro A; Meng TC; Lee J; Gaspari AA
    J Immunol; 2011 Aug; 187(4):1664-73. PubMed ID: 21765012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice.
    Ito H; Ando T; Ogiso H; Arioka Y; Seishima M
    Cancer Immunol Immunother; 2015 Apr; 64(4):429-36. PubMed ID: 25567751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-Derived Exosomes Attenuate TLR7-Mediated Mast Cell Activation.
    Cho KA; Cha JE; Kim J; Kim YH; Ryu KH; Woo SY
    Tissue Eng Regen Med; 2022 Feb; 19(1):117-129. PubMed ID: 34792754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon and Toll-Like Receptor 7 Response in COVID-19: Implications of Topical Imiquimod for Prophylaxis and Treatment.
    Szeto MD; Maghfour J; Sivesind TE; Anderson J; Olayinka JT; Mamo A; Runion TM; Dellavalle RP
    Dermatology; 2021; 237(6):847-856. PubMed ID: 34511591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells link immune sensing to antigen-avoidance behaviour.
    Plum T; Binzberger R; Thiele R; Shang F; Postrach D; Fung C; Fortea M; Stakenborg N; Wang Z; Tappe-Theodor A; Poth T; MacLaren DAA; Boeckxstaens G; Kuner R; Pitzer C; Monyer H; Xin C; Bonventre JV; Tanaka S; Voehringer D; Vanden Berghe P; Strid J; Feyerabend TB; Rodewald HR
    Nature; 2023 Aug; 620(7974):634-642. PubMed ID: 37438525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of mast cells to bacterial and fungal infection immunity.
    Piliponsky AM; Romani L
    Immunol Rev; 2018 Mar; 282(1):188-197. PubMed ID: 29431211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses - a randomized, placebo-controlled clinical trial.
    Eveleens Maarse BC; Ronner MN; Jansen MAA; Niemeyer-van der Kolk T; In 't Veld AE; Klaassen ES; Ahmad S; Itano A; McHale D; Moerland M
    Immunol Res; 2024 May; ():. PubMed ID: 38748319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
    Sun J; Dou W; Zhao Y; Hu J
    Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7 and TLR8 as targets in cancer therapy.
    Schön MP; Schön M
    Oncogene; 2008 Jan; 27(2):190-9. PubMed ID: 18176600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells are at the interface between the external environment and the inner organism.
    Ribatti D
    Front Med (Lausanne); 2023; 10():1332047. PubMed ID: 38239615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
    Assil S; Buters TP; Hameeteman PW; Hallard C; Treijtel N; Niemeyer-Van der Kolk T; de Kam ML; Florencia EFIII; Prens EP; van Doorn MBA; Rissmann R; Klarenbeek NB; Jansen MAA; Moerland M
    Front Immunol; 2023; 14():1197650. PubMed ID: 37545524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suprabasin-derived polypeptides: SBSN(50-63) induces inflammatory response via TLR4-mediated mast cell activation.
    Zhou T; Du X; Zhang L; Zheng Y; Jia T; Song X; Che D; Geng S
    Inflammopharmacology; 2023 Jun; 31(3):1329-1339. PubMed ID: 36745245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Mast Cells in Cutaneous Diseases.
    Numata T; Harada K; Nakae S
    Front Immunol; 2022; 13():923495. PubMed ID: 35874756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells.
    Hirobe S; Yamasaki T; Ito S; Quan YS; Kamiyama F; Tachibana M; Okada N
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.
    Johnson-Weaver BT; Choi HW; Yang H; Granek JA; Chan C; Abraham SN; Staats HF
    Front Immunol; 2021; 12():730346. PubMed ID: 34566991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-9 and IL-9-producing cells in tumor immunity.
    Wan J; Wu Y; Ji X; Huang L; Cai W; Su Z; Wang S; Xu H
    Cell Commun Signal; 2020 Mar; 18(1):50. PubMed ID: 32228589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian control of interferon-sensitive gene expression in murine skin.
    Greenberg EN; Marshall ME; Jin S; Venkatesh S; Dragan M; Tsoi LC; Gudjonsson JE; Nie Q; Takahashi JS; Andersen B
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5761-5771. PubMed ID: 32132203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles and relevance of mast cells in infection and vaccination.
    Fang Y; Xiang Z
    J Biomed Res; 2016 Jul; 30(4):253-63. PubMed ID: 26565602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian Gene Clock Regulates Psoriasis-Like Skin Inflammation in Mice.
    Ando N; Nakamura Y; Aoki R; Ishimaru K; Ogawa H; Okumura K; Shibata S; Shimada S; Nakao A
    J Invest Dermatol; 2015 Dec; 135(12):3001-3008. PubMed ID: 26291684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.